Florence Nightingale na Era Digital: “Onde estamos e para onde vamos?"

A Fundação Champalimaud, enquanto instituição prestadora de cuidados na área da oncologia e centro privilegiado de aprendizagem, promove anualmente uma conferência multidisciplinar onde aborda transversalmente o que de mais inovador e diferenciador se faz em oncologia. 

Maria João Rego

Sofia Pereira

Catarina Rosa

Rogelio Andrés-Luna

Carina Lopes

20 March 2022

In 2015, the Champalimaud Foundation established the International Training Academy in Robotic Colorectal Surgery

Interview with Amjad Parvaiz

As a young man, Amjad Parvaiz, now 54, wanted to become a “big trauma surgeon”. So after graduating from university in his home city of Lahore, in Pakistan, he moved to South Africa to do his trauma surgery training there. While in South Africa, in 1995, he says, “one of my bosses took me aside and said to me: ‘if you want to do 21st century surgery, go and learn laparoscopy.

09 March 2022

In just ten years, colorectal cancer cases have doubled in people under 50

Interview with Paulo Fidalgo

Paulo Fidalgo, 66, says that he has “two loves” at the Champalimaud Foundation: gastroenterology and oncological risk assessment. So it does not come as a surprise that he is both a gastroenterologist in the Digestive Unit of the Champalimaud Clinical Centre and the head of the Risk Assessment and Early Diagnosis Programme at this Centre.

24 February 2022

Now is the time to reduce global access inequalities to breast cancer treatment and management

The Lancet Breast Cancer Commission, a worldwide multidisciplinary team of leaders and patient advocates, published a few days ago a Comment article in the medical journal The Lancet calling for urgent action to ensure treatment equity for women with breast cancer no matter who they are and where they live. Fátima Cardoso, internationally renowned Director of the Breast Unit at the Champalimaud Foundation, is one of the authors and representative of the larger work group.

23 February 2022

Ana Luísa Correia awarded 2022 Pfizer Research Prize

Ana Luísa Correia joined the CF in December 2021. Prior to that, she worked for several years at the Basel University Hospital in Switzerland. During her stay there, she made breakthrough discoveries with potentially important therapeutic implications. She intends to pursue this line of work at the CF.

Subscribe to Cancer
Loading
Please wait...